Exploring Ocugen's Gene Therapy Prospects and Cash Flow Challenges

Ocugen's Gene Therapy Potential

This article delves into Ocugen's gene therapy products, highlighting their high potential in the market.

Financial Struggles

Ocugen is facing cash flow challenges, presenting obstacles for the company's growth trajectory.

Long-Term Investment Opportunity

For long-term investors, Ocugen is considered a speculative Buy, offering potential returns in the gene therapy sector.